These approaches could lead to the development of IL-12 immunotherapies that have important implications for the treatment of many different types of cancer in the years ahead. Stacy R.

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

"Our findings illuminate a crucial, yet previously unresolved mechanism in bacterial cancer therapy. The elucidated IL-10R hysteresis mechanism not only provides valuable insights but also serves ...